Mark Heinen
Patrimonio netto: 10 357 $ in data 31/05/2026
Patrimonio netto: 10 357 $ in data 31/05/2026
Mark Heinen currently works at Volato Group, Inc., as Chief Financial Officer from 2023.
Mr. Heinen also formerly worked at Daegis, Inc., as Chief Financial Officer from 2013 to 2016, Trintech, Inc., as CFO & Senior VP-Global Corporate Controller from 2017 to 2019, Better Therapeutics, Inc., as Chief Financial Officer & Head-Finance from 2021 to 2023, and Omnigo LLC, as Chief Financial Officer.
Mr. Heinen received his undergraduate degree and Masters Business Admin degree from the University of Oklahoma.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,2% | 21/04/2026 | 60.921 ( 0,2% ) | 10 357 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|
| Società | Posizione | Fine |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Direttore Finanziario/CFO | 27/11/2023 |
Trintech, Inc.
Trintech, Inc. Packaged SoftwareTechnology Services Provides account reconciliation and payment infrastructure software solutions | Direttore Finanziario/CFO | 10/09/2019 |
| DAEGIS INC | Direttore Finanziario/CFO | 01/01/2016 |
Omnigo LLC | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
University of Oklahoma
University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trintech, Inc.
Trintech, Inc. Packaged SoftwareTechnology Services Provides account reconciliation and payment infrastructure software solutions | Technology Services |
Daegis, Inc.
Daegis, Inc. Packaged SoftwareTechnology Services Provides application development, data management, migration and archiving software solutions | Technology Services |
Better Therapeutics, Inc.
Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
Omnigo LLC |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale